57 results
424B5
BLRX
Bioline Rx Ltd
3 Sep 21
Prospectus supplement for primary offering
4:29pm
the same parties;
an action between the same parties in the same matter is not pending in any Israeli court at the time the lawsuit is instituted … or punitive damages for any breach of the terms of the deposit agreement;
have no obligation to become involved in a lawsuit or other proceeding related
424B5
BLRX
Bioline Rx Ltd
25 Sep 20
Prospectus supplement for primary offering
4:30pm
in any Israeli court at the time the lawsuit is instituted in the foreign court; and
the judgment is enforceable according to the laws of Israel … or punitive damages for any breach of the terms of the deposit agreement;
have no obligation to become involved in a lawsuit or other proceeding
424B5
BLRX
Bioline Rx Ltd
28 May 20
Prospectus supplement for primary offering
12:00pm
the same parties;
an action between the same parties in the same matter is not pending in any Israeli court at the time the lawsuit is instituted … agreement;
have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf
F-3
BLRX
Bioline Rx Ltd
1 Aug 12
Shelf registration (foreign)
12:00am
of the relevant series may direct the time, method and place of conducting any lawsuit or other formal legal action seeking any remedy available … as a waiver of that right, remedy or Event of Default.
Before you are allowed to bypass your trustee and bring your own lawsuit or other formal legal
424B5
BLRX
Bioline Rx Ltd
17 May 13
Prospectus supplement for primary offering
12:00am
matter between the same parties;
an action between the same parties in the same matter is not pending in any Israeli court at the time the lawsuit … of the relevant series may direct the time, method and place of conducting any lawsuit or other formal legal action seeking any remedy available to the trustee
424B5
q63zj7nt
1 Apr 24
Prospectus supplement for primary offering
10:30am
F-3
nn9 foq35sm
29 Dec 23
Shelf registration (foreign)
4:15pm
424B5
7vufhf 3s
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
qb02culh1y4ezffirb
20 Sep 22
Prospectus supplement for primary offering
4:30pm
424B5
lo6wucva2vpy vzit62
3 Jun 20
Prospectus supplement for primary offering
8:33am
424B5
0af1liz gnh
4 Feb 19
Prospectus supplement for primary offering
5:52pm
424B5
ozh08henhxejb2 63i7
17 May 13
Prospectus supplement for primary offering
12:00am
F-3/A
zbs53kqqm8hiz
16 Oct 15
Shelf registration (foreign) (amended)
12:00am
424B5
6nowhp2cd54h51fcie
19 Jan 21
Prospectus supplement for primary offering
5:00pm
424B5
dy7ccj2pzf 423m6
21 Jan 21
Prospectus supplement for primary offering
4:31pm
F-3
ljmrckijd ehw01z62o
31 Dec 20
Shelf registration (foreign)
4:37pm
6-K
EX-10.2
6fbpjpbw
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
F-3
xb2lvkdf5rpr3fyqri9
26 Dec 18
Shelf registration (foreign)
4:11pm
20FR12B
EX-4.24
xmyiquy8
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
424B5
xp6vw
6 Feb 13
Prospectus supplement for primary offering
12:00am